臨床試驗

Cephea South America Feasibility Study

NCT：NCT07244939 · ACTIVE_NOT_RECRUITING

NCT IDNCT07244939

狀態ACTIVE_NOT_RECRUITING

開始日期2025-06-17

SponsorAbbott Medical Devices (INDUSTRY)

First posted2025-11-24

Last updated2026-09-11

簡要摘要

The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。